Barouch DH - Search Results

1

A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials.

Ehrenberg PK, Shangguan S, Issac B, Alter G, Geretz A, Izumi T, Bryant C, Eller MA, Wegmann F, Apps R, Creegan M, Bolton DL, Sekaly RP, Robb ML, Gramzinski RA, Pau MG, Schuitemaker H, Barouch DH, Michael NL, Thomas R. Ehrenberg PK, et al. Among authors: barouch dh. Sci Transl Med. 2019 Aug 28;11(507):eaaw4236. doi: 10.1126/scitranslmed.aaw4236. Sci Transl Med. 2019. PMID: 31462510 Free PMC article.

2

DNA vaccination for HIV-1 and SIV.

Barouch DH, Letvin NL. Barouch DH, et al. Intervirology. 2000;43(4-6):282-7. doi: 10.1159/000053995. Intervirology. 2000. PMID: 11251383 Review.

3

Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys.

Barouch DH, Letvin NL. Barouch DH, et al. Dev Biol (Basel). 2000;104:85-92. Dev Biol (Basel). 2000. PMID: 11713828

4

Prospects for vaccine protection against HIV-1 infection and AIDS.

Letvin NL, Barouch DH, Montefiori DC. Letvin NL, et al. Among authors: barouch dh. Annu Rev Immunol. 2002;20:73-99. doi: 10.1146/annurev.immunol.20.081501.094854. Epub 2001 Oct 4. Annu Rev Immunol. 2002. PMID: 11861598 Review.

5

Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.

Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, Havenga MJ, Goudsmit J, Letvin NL, Barouch DH. Sumida SM, et al. Among authors: barouch dh. J Virol. 2004 Mar;78(6):2666-73. doi: 10.1128/jvi.78.6.2666-2673.2004. J Virol. 2004. PMID: 14990686 Free PMC article.

6

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J. Barouch DH, et al. J Immunol. 2004 May 15;172(10):6290-7. doi: 10.4049/jimmunol.172.10.6290. J Immunol. 2004. PMID: 15128818

7

Challenges in the development of an HIV-1 vaccine.

Barouch DH. Barouch DH. Nature. 2008 Oct 2;455(7213):613-9. doi: 10.1038/nature07352. Nature. 2008. PMID: 18833271 Free PMC article. Review.

8

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.

Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH. Liu J, et al. Among authors: barouch dh. Nature. 2009 Jan 1;457(7225):87-91. doi: 10.1038/nature07469. Epub 2008 Nov 9. Nature. 2009. PMID: 18997770 Free PMC article.

9

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.

O'Brien KL, Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, Hutnick NA, Betts MR, Dubey SA, Goudsmit J, Shiver JW, Robertson MN, Casimiro DR, Barouch DH. O'Brien KL, et al. Among authors: barouch dh. Nat Med. 2009 Aug;15(8):873-5. doi: 10.1038/nm.1991. Epub 2009 Jul 20. Nat Med. 2009. PMID: 19620961 Free PMC article. Clinical Trial.

10

HIV-1 vaccine development after STEP.

Barouch DH, Korber B. Barouch DH, et al. Annu Rev Med. 2010;61:153-67. doi: 10.1146/annurev.med.042508.093728. Annu Rev Med. 2010. PMID: 20059334 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters